FOR SALE: SHARE IN MBC BEAMLINE 4.2.2 AT ALS The Molecular Biology Consortium (MBC) is an organization of 10 academic institutions that operates the synchrotron beam line 4.2.2 at the Advanced Light Source (Berkeley) for macromolecular crystallography. The Cleveland Center for Structural Biology is interested in selling its share in this consortium. Shareholders have guaranteed access to beam time, approximately 16-20 days each year, and beam time is available in 2-day slots. Since coming online in 2004, this beam line has yielded data that have been used to solve crystal structures by SAD, MAD, MIR and molecular replacement. For more information on MBC and beam line 4.2.2 please visit http://www.mbc-als.org/ Contact information: Dr. Menachem Shoham, Cleveland Center for Structural Biology E-mail: [EMAIL PROTECTED], Tel. 216-368-4665 |
